I fail to see the connection between charting and dealing with...

I fail to see the connection between charting and dealing with the FDA.
And by the way, yes the FDA/approval process is the most obvious catalyst, which holders clearly are banking on. However, there are a number of alternative scenarios that could drive this stock price. I remember not so long ago in this very thread, much discussion about gaps, candles etc calling for 50c share price...and here we are at 82c.
Using charts on illquid, event driven micro caps is the wrong way to invest.

And don't talk to me about MSB. The most dodgy biotech (sic) I've ever been involved in.
The first run, which I was on, started from float at 50c and was driven by their stem cell technology to repair bone breaks, knees etc. It was incredibly exciting and looked like it was a game changer. Turned out to be garbage.
Graft vs host was tech they actually bought, developed by someone else. MSB have no credibility in the biotech space, IMO.